Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver ... and the current treatment and management ...
Microbiome Changes in Chronic Liver Disease Highlight the Need for Personalized Treatment Nov. 18, 2024 — People with chronic liver disease have dramatic changes to the types and functions of ...
In a series of studies at McMaster, Dr. Schertzer’s research group demonstrated that treatment with QBECO SSI resulted in a marked reduction in liver fat, inflammation, and fibrosis in fatty liver ...
Patients with indeterminate chronic hepatitis B (CHB) phase are at risk of progressing to advanced liver disease and hepatocellular carcinoma (HCC), according to study results published in the Journal ...